Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $534,761 | 194 | 77.8% |
| Travel and Lodging | $73,900 | 160 | 10.7% |
| Consulting Fee | $69,599 | 41 | 10.1% |
| Food and Beverage | $8,687 | 157 | 1.3% |
| Unspecified | $724.09 | 2 | 0.1% |
| Education | $10.81 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $632,743 | 506 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $15,078 | 18 | $0 (2024) |
| UCB, Inc. | $10,030 | 6 | $0 (2024) |
| Incyte Corporation | $7,712 | 7 | $0 (2024) |
| UCB SA | $7,319 | 7 | $0 (2024) |
| Novartis Pharma AG | $4,725 | 2 | $0 (2023) |
| UCB Biosciences Inc. | $4,500 | 5 | $0 (2021) |
| Sandoz Inc. | $3,375 | 1 | $0 (2024) |
| UCB GmBH | $1,000 | 2 | $0 (2021) |
| Almirall LLC | $800.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166,352 | 105 | ABBVIE INC. ($138,256) |
| 2023 | $94,363 | 92 | AbbVie Inc. ($81,775) |
| 2022 | $89,998 | 76 | ABBVIE INC. ($84,783) |
| 2021 | $78,642 | 71 | AbbVie Inc. ($76,642) |
| 2020 | $38,191 | 26 | AbbVie Inc. ($34,651) |
| 2019 | $68,090 | 63 | AbbVie, Inc. ($64,590) |
| 2018 | $67,514 | 53 | AbbVie, Inc. ($67,514) |
| 2017 | $84,532 | 70 | AbbVie, Inc. ($84,532) |
All Payment Transactions
556 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $7,200.00 | General |
| 12/30/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $147.37 | General |
| 12/30/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $81.94 | General |
| 12/30/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $73.50 | General |
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $306.20 | General |
| 12/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $144.60 | General |
| 12/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $93.70 | General |
| 12/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $60.24 | General |
| 12/05/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $1,235.92 | General |
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $931.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,600.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $1,319.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $1,397.03 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Patient and physician preferences for attributes associated with biologic treatments for hidradenitis suppurativa | UCB, Inc. | $400.00 | 1 |
| CAIN457M2301,CAIN457M2302 | Novartis Pharmaceuticals Corporation | $324.09 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 194 | 368 | $60,686 | $13,087 |
| 2022 | 8 | 232 | 489 | $69,645 | $18,183 |
| 2021 | 9 | 312 | 651 | $85,475 | $24,636 |
| 2020 | 10 | 388 | 731 | $97,196 | $23,497 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 117 | $32,479 | $7,729 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 48 | $9,408 | $2,366 | 25.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 19 | 21 | $7,104 | $1,276 | 18.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 23 | 28 | $5,356 | $895.54 | 16.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 22 | 142 | $2,757 | $425.00 | 15.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 12 | 12 | $3,582 | $395.94 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 126 | $35,028 | $9,867 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 41 | $8,036 | $2,262 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $5,820 | $1,885 | 32.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 29 | 39 | $7,488 | $1,399 | 18.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 14 | 18 | $5,922 | $1,179 | 19.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 27 | 166 | $3,154 | $770.01 | 24.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 12 | 13 | $3,913 | $765.93 | 19.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 71 | $284.00 | $55.99 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 117 | $31,710 | $10,860 | 34.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 68 | $12,644 | $3,816 | 30.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 21 | $7,680 | $2,712 | 35.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 24 | 28 | $9,152 | $2,187 | 23.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 20 | 21 | $6,189 | $1,523 | 24.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 41 | 48 | $9,174 | $1,523 | 16.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 35 | 213 | $3,951 | $1,040 | 26.3% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 18 | 28 | $4,547 | $872.66 | 19.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 19 | 107 | $428.00 | $101.76 | 23.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 88 | 120 | $31,269 | $8,582 | 27.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 95 | 120 | $21,183 | $5,343 | 25.2% |
About Dr. Christopher Sayed, MD
Dr. Christopher Sayed, MD is a Dermatology healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225265903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Sayed, MD has received a total of $687,682 in payments from pharmaceutical and medical device companies, with $166,352 received in 2024. These payments were reported across 556 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($534,761).
As a Medicare-enrolled provider, Sayed has provided services to 1,126 Medicare beneficiaries, totaling 2,239 services with total Medicare billing of $79,403. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Chapel Hill, NC
- Active Since 06/19/2009
- Last Updated 10/07/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225265903
Products in Payments
- RINVOQ (Biological) $233,214
- Humira (Biological) $150,275
- HUMIRA (Biological) $149,370
- COSENTYX (Drug) $10,566
- Bimzelx (Biological) $9,585
- SKYRIZI (Biological) $5,368
- COSENTYX (Biological) $4,725
- OPZELURA (Drug) $2,522
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Chapel Hill
Stefan Weiss, Md, MD
Dermatology — Payments: $850,209
Dr. Sue Ellen Cox, M.d, M.D
Dermatology — Payments: $292,909
Donna Culton, Md, MD
Dermatology — Payments: $137,260
Dr. Chris Adigun, M.d, M.D
Dermatology — Payments: $129,211
Dr. Aida Lugo-Somolinos, Md, MD
Dermatology — Payments: $45,638
Dr. David Devries, M.d, M.D
Dermatology — Payments: $18,132